Toll-like receptor 4–Mitogen-activated protein kinase signaling pathway (TLR4–MAPK pathway)

The Toll-like receptor 4–Mitogen-activated protein kinase (TLR4–MAPK) signaling pathway is a fundamental axis of the innate immune system responsible for detecting and responding to microbial threats, particularly lipopolysaccharide (LPS) from Gram-negative bacteria (UniProt P33724). Upon ligand binding, TLR4 initiates a complex intracellular signaling cascade through adapter proteins like MyD88, which sequentially activates the MAPK family, including p38, JNK, and ERK (PubMed: 28250547). This activation culminates in the induction of pro-inflammatory cytokines such as TNF-α and IL-6, which are essential for host defense but can cause tissue damage if overproduced (PubMed: 30214644). Chronic or excessive activation of this pathway is a hallmark of various pathological states, including sepsis, autoimmune diseases, and chronic inflammatory conditions (PubMed: 21346100). Therapeutic strategies targeting this pathway include TLR4 antagonists like Resatorvid and various small-molecule inhibitors of downstream MAPK enzymes (PubMed: 19710304). However, because this pathway is central to immune surveillance, its inhibition poses significant challenges, including the risk of opportunistic infections and potential off-target effects from kinase inhibition (PubMed: 25156947).

Other names

TLR4-MAPK axisTLR4-mediated MAPK activationToll-like receptor 4 signaling cascade

Inhibition of TLR4-mediated activation of the MAPK cascade to suppress pro-inflammatory gene expression.